Type I interferon signature may influence the effect of belimumab on immunoglobulin levels, including rheumatoid factor in Sjögren's syndrome
Quartuccio, L.; Mavragani, C.P.; Nezos, A.; Gandolfo, S.; Tzioufas, A.G.; De Vita, S.
Clinical and Experimental Rheumatology 35(4): 719-720
2017
ISSN/ISBN: 0392-856X PMID: 28281461 Document Number: 694481
Document emailed within 1 workday
Related Documents
De Vita, S.; Quartuccio, L.; Salvin, S.; Picco, L.; Scott, C.A.; Rupolo, M.; Fabris, M. 2014: Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy Clinical and Experimental Rheumatology 32(4): 490-494Barcelos, F.; Abreu, I.; Patto, J.é V.; Trindade, H.él.; Teixeira, A. 2009: Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in Sjögren's syndrome Acta Reumatologica Portuguesa 34(4): 608-612
Acaba, L.; Mangual, A.; Vélez García, E. 2000: Excellent response to interferon therapy in a patient with hypereosinophilic syndrome and elevated serum immunoglobulin e levels Boletin de la Asociacion Medica de Puerto Rico 92(4-8): 59-62
Maszkiewicz, W. 1983: Serum immunoglobulin levels in newborn infants with the intrauterine dystrophy syndrome. II. Immunoglobulin levels in relation to the degree of maturity Pediatria Polska 58(3): 237-242
Bendtzen, K.; Hansen, P.R.; Rieneck, K. 2004: Spironolactone inhibits production of proinflammatory cytokines, including tumor necrosis factor-alpha and interferon-gamma and has potential effect in the treatment of arthritis Ugeskrift for Laeger 166(37): 3203-3207
Kosrirukvongs, P.; Ngowyutagon, P.; Pusuwan, P.; Koolvisoot, A.; Nilganuwong, S. 2012: Prevalence of dry eye syndrome and Sjogren's syndrome in patients with rheumatoid arthritis Journal of the Medical Association of Thailand 95(Suppl 4): S61-S69
Shiozawa, S.; Shiozawa, K.; Shimizu, S.; Tanaka, Y.; Morimoto, I.; Yoshihara, R.; Kuroki, Y.; Hashimoto, M.; Fujita, T. 1990: Immunoreactive circulating alpha-interferon is low in Sjögren's syndrome British Journal of Rheumatology 29(1): 50-52
Ezaki, I.; Wada, T.; Nonaka, S.; Kamimiya, M.; Nobenaga, T. 1988: Expanded clinical and basic profile of rheumatoid factors. 6. Rheumatoid factors in patients with Sjögren's syndrome Ryumachi 28(6): 425-428
Oxholm, P. 1989: Epithelial immunoglobulin deposits and Langerhans cells in patients with primary Sjögren's syndrome Danish Medical Bulletin 36(4): 358-368
Lvovsky, E.A.; D'Souza, J.; Eng, D.; D'Souza, D.; Lvovsky, B.; Hetland, R.; Craver, W.L.; Sobel, S.H. 1988: Tumor response to interferon inducer and radiation effect of serum interferon levels Journal of Biological Regulators and Homeostatic Agents 2(1): 1-6
Yoshino, S.; Morishige, T.; Fujimori, J.; Kawashima, K. 1982: A case of myasthenia associated with rheumatoid arthritis and Sjögren's syndrome Ryumachi 22(4): 315-320
Ambrus, J.L.; Poiesz, B.J.; Lillie, M.A.; Stadler, I.; Di Berardino, L.A.; Chadha, K.C. 1989: Interferon and interferon inhibitor levels in patients infected with varicella-zoster virus, acquired immunodeficiency syndrome, acquired immunodeficiency syndrome-related complex, or Kaposi's sarcoma, and in normal individuals American Journal of Medicine 87(4): 405-407
Ai, Y.; Liu, S.-y. 2004: Influence of transforming growth factor-beta2 on production of tumor necrosis factor-alpha and interferon-gamma from placenta of intrahepatic cholestasis of pregnancy Zhonghua Fu Chan Ke Za Zhi 39(5): 322-325
Goodwin, J.S.; Ceuppens, J.L.; Rodriguez, M.A. 1983: Administration of nonsteroidal anti-inflammatory agents in patients with rheumatoid arthritis. Effects on indexes of cellular immune status and serum rheumatoid factor levels JAMA 250(18): 2485-2488
Nemoto, Y.; Katayama, Y.; Sugiyama, K.; Kudo, K.; Matsuoka, T.; Nagata, N.; Takatani, O.; Kikuchi, K.; Aida, S. 1991: A case of broncho-bronchiolitis obliterans associated with rheumatoid arthritis and Sjögren's syndrome Nihon Kyobu Shikkan Gakkai Zasshi 29(9): 1180-1185
Lin, L.-H.; Tsai, C.-N.; Liu, M.-F.; Wang, C.-R. 2005: Common variable immunodeficiency mimicking rheumatoid arthritis with Sjögren's syndrome Journal of Microbiology Immunology and Infection 38(5): 358-360
Mizuno, T.; Hashimoto, T.; Hibino, N.; Nakamae, K.; Masaoka, A. 1988: A case of myasthenia gravis associated with rheumatoid arthritis, Sjögren's syndrome, hypergammaglobulinemia and hyperthyroidism Nihon Kyobu Geka Gakkai 36(7): 1191-1193
Fujimori, J.; Yoshino, S.; Morishige, T.; Kishimoto, M.; Suzuki, N.; Ohba, H. 1987: A case of rheumatoid arthritis with systemic lupus erythematosus, Sjögren's syndrome and Crohn's disease Ryumachi 27(4): 294-300
Nelson, J.D.; Friedlaender, M.; Yeatts, R.P.; Yee, R.; McDermott, M.; Orlin, S.; Gallagher, S.C.; Shrotriya, R.C. 1998: Oral pilocarpine for symptomatic relief of keratoconjunctivitis sicca in patients with Sjögren's syndrome. the MGi PHARMA Sjögren's Syndrome Study Group Advances in Experimental Medicine and Biology 438: 979-983
Koski, H.; Konttinen, Y.T.; Hietanen, J.; Tervo, T.; Malmström, M. 1997: Epidermal growth factor, transforming growth factor-alpha, and epidermal growth factor receptor in labial salivary glands in Sjögren's syndrome Journal of Rheumatology 24(10): 1930-1935